← Back to headlines
Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales
If middle-class Americans lose their jobs to AI, that could mean fewer cash sales of weight-loss drugs like Zepbound.
17 Mar, 18:28 — 17 Mar, 18:28
Related Stories
Signs of depression in teenagers that parents often overlook
3h ago
74-year-old woman dies after being pulled unconscious from sea in Katerini, Greece
3h ago
August Depression: Psychologists Advise on Coping with End-of-Summer Sadness
3h ago
Heat Warnings Overlook Common Health Problems Exacerbated by Extreme Temperatures
3h ago